Compare $CLPT vs $CV | Chartloom

Compare

$CLPT vs $CV

Clearpoint Neuro Inc · CapsoVision Inc

CLPT

Clearpoint Neuro Inc

CapsoVision Inc

Compare $CLPT vs $CV

Comparing Clearpoint Neuro Inc and CapsoVision Inc

CLPTClearpoint Neuro Inc

CVCapsoVision Inc

CLPTClearpoint Neuro Inc

Market cap

$314M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.82x

Rev growth (TTM)

25.9%

YTD performance

-25.3%

52W performance

-64.6%

FCF yield

-10.0%

CVCapsoVision Inc

Market cap

$329M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

18.89x

Rev growth (TTM)

-31.7%

YTD performance

-35.6%

52W performance

43.3%

FCF yield

-8.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLPT

Detailed metrics comparison

CLPT

Clearpoint Neuro Inc

CapsoVision Inc

Market Cap

CLPT$314M

CV$329M

Enterprise Value

CLPT$335M

CV$320M

Price

CLPT$10.48

CV$6.59

P/E Ratio

CLPTN/A

CVN/A

P/S Ratio

CLPT7.43x

CV23.70x

EV/Sales

CLPT7.93x

CV23.05x

EV/EBITDA

CLPT0.00x

CV0.00x

P/B Ratio

CLPT30.84x

CV24.94x

P/FCF Ratio

CLPTN/A

CVN/A

EV/FCF

CLPT-10.71x

CV-11.48x

PEG Ratio

CLPTN/A

CVN/A

Forward P/E (NTM)

CLPTN/A

CVN/A

Forward P/S (NTM)

CLPT5.82x

CV18.89x

Revenue (TTM)

CLPT$42M

CV$14M

Revenue Growth (YoY)

CLPT25.9%

CV-31.7%

Forward Rev Growth

CLPT15.4%

CV33.3%

Gross Margin (TTM)

CLPT62.6%

CV50.9%

Operating Margin (TTM)

CLPT0.0%

CV0.0%

EBITDA Margin (TTM)

CLPT-69.3%

CV-215.5%

Net Margin (TTM)

CLPT-81.8%

CV-214.7%

FCF Margin (TTM)

CLPT-74.0%

CV-200.8%

Net Income (TTM)

CLPT$-35M

CV$-30M

FCF (TTM)

CLPT$-31M

CV$-28M

EPS (TTM)

CLPT-$1.15

CV-$0.60

ROE (TTM)

CLPT-18809.0%

CV-17785.0%

ROA (TTM)

CLPT-4087.0%

CV-13507.0%

ROIC (TTM)

CLPT-5494.0%

CV-17785.0%

Cash

CLPT$29M

CV$9M

Debt

CLPT$50M

CV$0

Net Cash/Debt

CLPT$-21M

CV$9M

Current Ratio (TTM)

CLPT4.74x

CV3.35x

Quick Ratio (TTM)

CLPT3.75x

CV2.31x

Debt/Equity (TTM)

CLPT4.66x

CV0.00x

Debt/Assets (TTM)

CLPT0.0%

CV0.0%

Interest Coverage (TTM)

CLPTN/A

CVN/A

Net Debt/EBITDA (TTM)

CLPT0.00x

CV0.00x

Beta

CLPT1.31

CV-1.80

52W Performance

CLPT-64.6%

CV43.3%

YTD Performance

CLPT-25.3%

CV-35.6%

% from 52W High

CLPT-65.2%

CV-57.1%

% from 52W Low

CLPT26.7%

CV50.5%

Asset Turnover (TTM)

CLPT0.50x

CV0.63x

FCF Yield (TTM)

CLPT-10.0%

CV-8.5%

Earnings Yield (TTM)

CLPT-11.0%

CV-9.1%

Dividend Yield (TTM)

CLPTN/A

CVN/A

Rule of 40

CLPT-48.2

CV-232.5

EV/GP/RG

CLPT0.46

CV1.78

Ticker research

View CLPT research View CV research

Metric	CLPT Clearpoint Neuro Inc	CV CapsoVision Inc
Market & Valuation
Market Cap	$314M	$329M
Enterprise Value	$335M	$320M
Price	$10.48	$6.59
P/E Ratio	N/A	N/A
P/S Ratio	7.43x	23.70x
EV/Sales	7.93x	23.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	30.84x	24.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.71x	-11.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.82x	18.89x
Revenue & Growth
Revenue (TTM)	$42M	$14M
Revenue Growth (YoY)	25.9%	-31.7%
Forward Rev Growth	15.4%	33.3%
Profitability
Gross Margin (TTM)	62.6%	50.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-69.3%	-215.5%
Net Margin (TTM)	-81.8%	-214.7%
FCF Margin (TTM)	-74.0%	-200.8%
Net Income (TTM)	$-35M	$-30M
FCF (TTM)	$-31M	$-28M
EPS (TTM)	-$1.15	-$0.60
ROE (TTM)	-18809.0%	-17785.0%
ROA (TTM)	-4087.0%	-13507.0%
ROIC (TTM)	-5494.0%	-17785.0%
Financial Health
Cash	$29M	$9M
Debt	$50M	$0
Net Cash/Debt	$-21M	$9M
Current Ratio (TTM)	4.74x	3.35x
Quick Ratio (TTM)	3.75x	2.31x
Debt/Equity (TTM)	4.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	-1.80
52W Performance	-64.6%	43.3%
YTD Performance	-25.3%	-35.6%
% from 52W High	-65.2%	-57.1%
% from 52W Low	26.7%	50.5%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.63x
FCF Yield (TTM)	-10.0%	-8.5%
Earnings Yield (TTM)	-11.0%	-9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-48.2	-232.5
EV/GP/RG	0.46	1.78
Ticker research	View CLPT research	View CV research

Valuation

P/S Ratio

CLPT

7.43x

23.70x

EV/FCF

-11.48x

CLPT

-10.71x

Growth & revenue

Revenue Growth TTM

CLPT

25.9%

-31.7%

Forward Revenue Growth

33.3%

CLPT

15.4%

Profitability & performance

Gross Margin

CLPT

62.6%

50.9%

ROE

-17785.0%

CLPT

-18809.0%

FCF Yield %

-8.5%

CLPT

-10.0%

52-Week Performance

43.3%

CLPT

-64.6%

Detailed metrics comparison

CLPT

Clearpoint Neuro Inc

CapsoVision Inc

Market Cap

CLPT$314M

CV$329M

Enterprise Value

CLPT$335M

CV$320M

Price

CLPT$10.48

CV$6.59

P/E Ratio

CLPTN/A

CVN/A

P/S Ratio

CLPT7.43x

CV23.70x

EV/Sales

CLPT7.93x

CV23.05x

EV/EBITDA

CLPT0.00x

CV0.00x

P/B Ratio

CLPT30.84x

CV24.94x

P/FCF Ratio

CLPTN/A

CVN/A

EV/FCF

CLPT-10.71x

CV-11.48x

PEG Ratio

CLPTN/A

CVN/A

Forward P/E (NTM)

CLPTN/A

CVN/A

Forward P/S (NTM)

CLPT5.82x

CV18.89x

Revenue (TTM)

CLPT$42M

CV$14M

Revenue Growth (YoY)

CLPT25.9%

CV-31.7%

Forward Rev Growth

CLPT15.4%

CV33.3%

Gross Margin (TTM)

CLPT62.6%

CV50.9%

Operating Margin (TTM)

CLPT0.0%

CV0.0%

EBITDA Margin (TTM)

CLPT-69.3%

CV-215.5%

Net Margin (TTM)

CLPT-81.8%

CV-214.7%

FCF Margin (TTM)

CLPT-74.0%

CV-200.8%

Net Income (TTM)

CLPT$-35M

CV$-30M

FCF (TTM)

CLPT$-31M

CV$-28M

EPS (TTM)

CLPT-$1.15

CV-$0.60

ROE (TTM)

CLPT-18809.0%

CV-17785.0%

ROA (TTM)

CLPT-4087.0%

CV-13507.0%

ROIC (TTM)

CLPT-5494.0%

CV-17785.0%

Cash

CLPT$29M

CV$9M

Debt

CLPT$50M

CV$0

Net Cash/Debt

CLPT$-21M

CV$9M

Current Ratio (TTM)

CLPT4.74x

CV3.35x

Quick Ratio (TTM)

CLPT3.75x

CV2.31x

Debt/Equity (TTM)

CLPT4.66x

CV0.00x

Debt/Assets (TTM)

CLPT0.0%

CV0.0%

Interest Coverage (TTM)

CLPTN/A

CVN/A

Net Debt/EBITDA (TTM)

CLPT0.00x

CV0.00x

Beta

CLPT1.31

CV-1.80

52W Performance

CLPT-64.6%

CV43.3%

YTD Performance

CLPT-25.3%

CV-35.6%

% from 52W High

CLPT-65.2%

CV-57.1%

% from 52W Low

CLPT26.7%

CV50.5%

Asset Turnover (TTM)

CLPT0.50x

CV0.63x

FCF Yield (TTM)

CLPT-10.0%

CV-8.5%

Earnings Yield (TTM)

CLPT-11.0%

CV-9.1%

Dividend Yield (TTM)

CLPTN/A

CVN/A

Rule of 40

CLPT-48.2

CV-232.5

EV/GP/RG

CLPT0.46

CV1.78

Ticker research

View CLPT research View CV research

Metric	CLPT Clearpoint Neuro Inc	CV CapsoVision Inc
Market & Valuation
Market Cap	$314M	$329M
Enterprise Value	$335M	$320M
Price	$10.48	$6.59
P/E Ratio	N/A	N/A
P/S Ratio	7.43x	23.70x
EV/Sales	7.93x	23.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	30.84x	24.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.71x	-11.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.82x	18.89x
Revenue & Growth
Revenue (TTM)	$42M	$14M
Revenue Growth (YoY)	25.9%	-31.7%
Forward Rev Growth	15.4%	33.3%
Profitability
Gross Margin (TTM)	62.6%	50.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-69.3%	-215.5%
Net Margin (TTM)	-81.8%	-214.7%
FCF Margin (TTM)	-74.0%	-200.8%
Net Income (TTM)	$-35M	$-30M
FCF (TTM)	$-31M	$-28M
EPS (TTM)	-$1.15	-$0.60
ROE (TTM)	-18809.0%	-17785.0%
ROA (TTM)	-4087.0%	-13507.0%
ROIC (TTM)	-5494.0%	-17785.0%
Financial Health
Cash	$29M	$9M
Debt	$50M	$0
Net Cash/Debt	$-21M	$9M
Current Ratio (TTM)	4.74x	3.35x
Quick Ratio (TTM)	3.75x	2.31x
Debt/Equity (TTM)	4.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.31	-1.80
52W Performance	-64.6%	43.3%
YTD Performance	-25.3%	-35.6%
% from 52W High	-65.2%	-57.1%
% from 52W Low	26.7%	50.5%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.63x
FCF Yield (TTM)	-10.0%	-8.5%
Earnings Yield (TTM)	-11.0%	-9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-48.2	-232.5
EV/GP/RG	0.46	1.78
Ticker research	View CLPT research	View CV research